American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Business

Teladoc stock forms a giant double bottom: will it rise after earnings?

by admin April 29, 2025
April 29, 2025
Teladoc stock forms a giant double bottom: will it rise after earnings?

Teladoc Health stock price continues to crash and is hovering at its lowest level on record ahead of its first-quarter earnings. It was trading at $7.16 on Monday, meaning that it has crashed by 21% this year and 46% in the last 12 months. This article explores why the TDOC share price has imploded and what to expect in the coming weeks.

Why Teladoc Health stock price crashed

Teladoc Health is an American company at the intersection of health and technology. It is the biggest player in the telehealth industry, helping customers communicate and receive advice from doctors from across the country. 

The company’s business boomed during the COVID-19 pandemic as many patients embraced telehealth. This growth pushed its stock to a record high and its market capitalization to over $46 billion. 

Teladoc leveraged this growth to expand its business through strategic acquisitions. It paid over $18.5 billion to acquire Livongo Health, a similar company that focuses on the diabetes sector. This acquisition did not work ou, and the company took a large charge on it. It made a $13.4 billion goodwill impairment, a sign that Livongo’s valuation was not as expected. 

Teladoc Health’s performance is in line with other top companies that boomed during the pandemic and then lost momentum when it ended. Other notable companies include PayPal, Zoom Video, Etsy, and Wayfair.

Read more: Teladoc (TDOC) stock price analysis and the fall from grace

After seeing strong growth at the time, Teladoc’s business has stalled. Its revenue doubled from $1 billion in 2020 to $2.03 billion in 2021. It then peaked at $2.6 billion in 2023 and recoiled to $2.56 billion last year. 

Analysts are not optimistic about Teladoc as demand for telehealth services wanes. Their average revenue estimates for 2025 and 2026 are $2.52 billion and $2.51 billion. The company’s guided range for its revenue is between $2.468 billion and $2.57 billion.

TDOC earnings ahead

The most recent financial results showed that its business deteriorated in the fourth quarter. Its revenue dropped by 3% to $640 million, while the adjusted EBITDA plunged to $74.8 million from $114.4 million in the same quarter a year earlier. 

Most of the weakness came from the BetterHelp segment, whose revenue dropped to $250 million from $276 million a year earlier. The integrated care segment’s revenue rose slightly to $391 million. 

Analysts are pessimistic about Teladoc’s business, with the average revenue estimate at $619 million, a 4.16% decrease from the same period last year. They expect that its net loss per share will improve from 43 cents to 36 cents.

The only positive on Teladoc is that its balance sheet is still strong as the company ended the quarter with over $1.2 billion in cash and short-term investments. This cash balance matches with its current market cap.

Teladoc stock technical analysis and potential scenarios

TDOC stock chart | Source: TradingView

The daily chart shows that the TDOC share price has crashed in the past few months. It peaked at $15.20 in March and then retreated to a low of $6.5 as recession odds rose in the United States.

The stock has formed a giant double-bottom pattern at $6.77 since this price was also the lowest level in August last year. Its neckline is at $15.19, up by 124% from the current level. 

The Teladoc share price remains below all moving averages. Therefore, while TDOC is risky, there is a likelihood that it will bounce back and possibly retest the important resistance level at $8.77, up by 23% from the current level. The other scenario is where its results are so bad such that the stock crashes and retests the year-to-date low of 

Read more: Teladoc Health stock: extremely oversold, rebound likely

The post Teladoc stock forms a giant double bottom: will it rise after earnings? appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Spotify stock may offer buying opportunity after Q1 results, says analyst
next post
Europe markets open: stocks edge higher; auto sector drags on Volvo, Porsche warnings

Related Posts

Is it safe to buy the Enterprise’s share...

November 25, 2024

Affirm stock price analysis: to go beast mode...

October 13, 2024

Paramount Global lays off about 800 employees, a...

February 15, 2024

Indian markets close: Sensex tops 80K, Nifty hits...

April 23, 2025

Red Lobster files for bankruptcy, but restaurants will...

May 22, 2024

The Body Shop shuts down in the U.S....

March 14, 2024

VIG, DGRW, DGRO are popular; but are they...

October 20, 2024

Could the Rolls-Royce share price suffer a harsh...

November 11, 2024

AMD stock price forecast after crashing to a...

March 25, 2025

Are there more gains ahead for AppLovin?

October 23, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • Oil prices face litmus test as US-Iran nuclear talks, OPEC meeting to shape market next week

      June 29, 2025
    • GMS stock jumps 29% on takeover interest from Home Depot, QXO, analysts raise PTs

      June 22, 2025
    • Japan’s rice price surge: what’s driving it and why it could spark a political crisis

      June 22, 2025
    • BofA raises STOXX 600 target amid resilient global growth, warns on Mideast risks

      June 22, 2025
    • Palantir co-founder: US must prevent Iranian nukes

      June 22, 2025

    Categories

    • Business (3,255)
    • Investing (2,558)
    • Latest News (2,001)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved